Stocks in play: NeonMind Biosciences Inc.
Announced today it is setting up to offer low dose intravenous ketamine therapy for mood and anxiety disorders (IV-Ket) as an initial treatment at its recently announced, inaugural specialty mental health clinic location in Mississauga, Ontario, pending clinic licensing. NeonMind Biosciences Inc. shares C.NEON are trading unchanged at $0.06.
Read:
Meal Kits, Menus and Snack Aisles are All Bringing More Vegan-Friendly Options to Consumers
Reducing the Risks of Adverse Reactions to Covid Vaccines May Also Reduce Hesitancy and Injuries
Growing Plant-Based Protein Wholesalers Seizing Upon Market’s Appetite for Vegan Options
Therapy Shake-Up Called for by Mental Health Experts Seeking Solutions for Mental Health Crisis
Pharmacies and In-Clinic Testing Set to Remain as Covid-19 Numbers Shift into Post-Pandemic Phase